These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29573355)

  • 1. Association of plasma neopterin with risk of an inpatient hospital diagnosis of atrial fibrillation: results from two prospective cohort studies.
    Zuo H; Nygård O; Ueland PM; Vollset SE; Svingen GFT; Pedersen ER; Midttun Ø; Meyer K; Nordrehaug JE; Nilsen DWT; Tell GS
    J Intern Med; 2018 Jun; 283(6):578-587. PubMed ID: 29573355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation.
    Svingen GFT; Zuo H; Ueland PM; Seifert R; Løland KH; Pedersen ER; Schuster PM; Karlsson T; Tell GS; Schartum-Hansen H; Olset H; Svenningsson M; Strand E; Nilsen DW; Nordrehaug JE; Dhar I; Nygård O
    Int J Cardiol; 2018 Sep; 267():100-106. PubMed ID: 29957250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Concentrations and Dietary Intakes of Choline and Betaine in Association With Atrial Fibrillation Risk: Results From 3 Prospective Cohorts With Different Health Profiles.
    Zuo H; Svingen GFT; Tell GS; Ueland PM; Vollset SE; Pedersen ER; Ulvik A; Meyer K; Nordrehaug JE; Nilsen DWT; Bønaa KH; Nygård O
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ-induced inflammatory markers and the risk of cancer: the Hordaland Health Study.
    Zuo H; Tell GS; Vollset SE; Ueland PM; Nygård O; Midttun Ø; Meyer K; Ulvik A; Eussen SJ
    Cancer; 2014 Nov; 120(21):3370-7. PubMed ID: 24948355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neopterin as an Effect Modifier of the Cardiovascular Risk Predicted by Total Homocysteine: A Prospective 2-Cohort Study.
    Bjørnestad EØ; Borsholm RA; Svingen GFT; Pedersen ER; Seifert R; Midttun Ø; Ueland PM; Tell GS; Bønaa KH; Nygård O
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients With Atrial Fibrillation.
    Benz AP; Aeschbacher S; Krisai P; Moschovitis G; Blum S; Meyre P; Blum MR; Rodondi N; Di Valentino M; Kobza R; De Perna ML; Bonati LH; Beer JH; Kühne M; Osswald S; Conen D;
    J Am Heart Assoc; 2021 Apr; 10(8):e019168. PubMed ID: 33843247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking, plasma cotinine and risk of atrial fibrillation: the Hordaland Health Study.
    Zuo H; Nygård O; Vollset SE; Ueland PM; Ulvik A; Midttun Ø; Meyer K; Igland J; Sulo G; Tell GS
    J Intern Med; 2018 Jan; 283(1):73-82. PubMed ID: 28940460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transsulfuration metabolites and the association with incident atrial fibrillation - An observational cohort study among Norwegian patients with stable angina pectoris.
    Svenningsson MM; Svingen GFT; Lysne V; Ueland PM; Tell GS; Pedersen ER; Dhar I; Nilsen DW; Nygård O
    Int J Cardiol; 2020 Oct; 317():75-80. PubMed ID: 32389762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
    Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Njølstad I; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Mathiesen E; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
    Circulation; 2017 Oct; 136(17):1588-1597. PubMed ID: 29038167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction.
    Bas HA; Aksoy F; Icli A; Varol E; Dogan A; Erdogan D; Ersoy I; Arslan A; Ari H; Bas N; Sutcu R; Ozaydin M
    Scand J Clin Lab Invest; 2017 Apr; 77(2):77-82. PubMed ID: 27905214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort.
    Cadby G; McArdle N; Briffa T; Hillman DR; Simpson L; Knuiman M; Hung J
    Chest; 2015 Oct; 148(4):945-952. PubMed ID: 25927872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative C-reactive protein and atrial fibrillation after off-pump coronary bypass surgery.
    Kinoshita T; Asai T; Takashima N; Hosoba S; Suzuki T; Kambara A; Matsubayashi K
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1298-303. PubMed ID: 21514836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Barassi A; Pezzilli R; Morselli-Labate AM; Lombardi F; Belletti S; Dogliotti G; Corsi MM; Merlini G; Melzi d'Eril GV
    Can J Cardiol; 2012; 28(5):537-41. PubMed ID: 22552174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein, left atrial volume, and atrial fibrillation: a prospective study in high-risk elderly.
    Casaclang-Verzosa G; Barnes ME; Blume G; Seward JB; Gersh BJ; Cha SS; Bailey KR; Tsang TS
    Echocardiography; 2010 Apr; 27(4):394-9. PubMed ID: 20070356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
    Conway DS; Buggins P; Hughes E; Lip GY
    J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
    Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
    Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein and atrial fibrillation: Insights from epidemiological and Mendelian randomization studies.
    Li X; Peng S; Wu X; Guan B; Tse G; Chen S; Zhou G; Wei Y; Gong C; Lu X; Xu J; Wu S; Liu S
    Nutr Metab Cardiovasc Dis; 2022 Jun; 32(6):1519-1527. PubMed ID: 35428542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma (IFN-γ)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland Health Study.
    Apalset EM; Gjesdal CG; Ueland PM; Øyen J; Meyer K; Midttun Ø; Eide GE; Tell GS
    Osteoporos Int; 2014 Aug; 25(8):2067-75. PubMed ID: 24817202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single and persistent elevation of C-reactive protein levels and the risk of atrial fibrillation in a general population: The Ansan-Ansung Cohort of the Korean Genome and Epidemiology Study.
    Lee Y; Park HC; Shin JH; Lim YH; Shin J; Park JK
    Int J Cardiol; 2019 Feb; 277():240-246. PubMed ID: 30409736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation.
    Chatterjee NA; Chae CU; Kim E; Moorthy MV; Conen D; Sandhu RK; Cook NR; Lee IM; Albert CM
    JACC Heart Fail; 2017 Aug; 5(8):552-560. PubMed ID: 28624486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.